Clinical Trial Update: G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether granulocyte colony-stimulating factor can prevent chemotherapy-induced neutropenia in women with breast cancer; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 2 | Status: COMPLETED